Tel Aviv, Dec 7 (IANS) Israel-based RedHill Biopharma on Tuesday announced that its Covid pill Opaganib is expected to be unaffected by mutations associated
Israel-based RedHill Biopharma on Tuesday announced that its Covid pill Opaganib is expected to be unaffected by mutations associated with Omicron and other known Coronavirus variants of concern.